Add BrightSurf on Google Email

The latest issue of NeuroRehabilitation focuses on the important role of neuropsychiatry in evaluating and managing the emotional and behavioral consequences of neurological injury

The journal highlights the complexities of neurological injury and neurodegenerative diseases, emphasizing virtual care as a potential solution. Identifying and treating neuropsychiatric symptoms is crucial for effective rehabilitation.

SourceIOS Press·JournalNeuroRehabilitation An International Interdisciplinary Journal·TypeObservational study·DateOct 2, 2023

Insilico Medicine and University of Cambridge present new approach to discover targets for Alzheimer’s and other diseases with protein phase separation

Researchers identified potential therapeutic targets for Alzheimer's disease and other conditions using a new approach combining AI-driven target identification with protein phase separation analysis. The study provides insights into the role of protein phase separation in human disease and its potential as a therapeutic target.

SourceInSilico Medicine·JournalProceedings of the National Academy of Sciences·DateSep 25, 2023

UCI researchers announce publication of an open-label clinical trial suggesting that N-acetylglucosamine restores neurological function in Multiple Sclerosis patients

A study published by UCI researchers found that N-acetylglucosamine reduced multiple inflammation and neurodegeneration markers in patients with Multiple Sclerosis. The dietary supplement also improved neurological function in 30% of patients, suggesting a potential new treatment for the condition.

SourceUniversity of California - Irvine·JournalJournal of Neuroinflammation·TypeRandomized controlled/clinical trial·DateSep 14, 2023

Pitt researchers to study Alzheimer’s disease in marmosets

Researchers developed a new model of hereditary Alzheimer's disease in marmosets by introducing mutations into the PSEN1 gene, which causes early-onset disease in humans. The study aims to characterize and validate genetic, molecular, functional, and cognitive features of aging and Alzheimer's disease in these animals.

SourceUniversity of Pittsburgh·JournalAlzheimer s & Dementia Translational Research & Clinical Interventions·DateSep 6, 2023

Molecule reduces inflammation in Alzheimer’s models

A new molecule called A11 has been found to reduce inflammation and improve memory in models of Alzheimer's disease. By targeting the genetic transcription factor PU.1, A11 suppresses inflammatory gene expression in microglia immune cells, leading to reduced neurodegeneration and improved cognition.

SourcePicower Institute at MIT·JournalJournal of Experimental Medicine·TypeExperimental study·DateAug 29, 2023

Phyllodulcin could be a potential candidate for treating Alzheimer’s disease, find Sahmyook University researchers

Researchers from Sahmyook University found that phyllodulcin, a natural sweetener found in hydrangeas, can efficiently inhibit amyloid beta (Aβ) aggregation and dissociate its aggregates in an animal model study. The study suggests that phyllodulcin may be useful in delaying the onset and progression of Alzheimer's disease.

SourceSahmyook University·JournalBiomedicine & Pharmacotherapy·TypeExperimental study·DateJul 27, 2023

Cognitive rescue in aging through prior training

A new study published in Aging (Albany NY) suggests that prior training can rescue cognitive decline in aging by improving task performance and strengthening memory processes. The research, conducted on rats, found that prior training enhanced short-term and intermediate memory, while also enabling encoding-boosted long-term memory.

SourceImpact Journals LLC·JournalAging-US·TypeExperimental study·DateJul 19, 2023

Structural biology: Molecular scissors caught in the act

Researchers have successfully visualized the three-dimensional structure of human tRNA splicing endonuclease TSEN, a crucial enzyme in tRNA maturation. The study reveals how TSEN recognizes and excises introns from precursor tRNAs, shedding light on its role in neurodegenerative disorders like pontocerebellar hypoplasia.

SourceGoethe University Frankfurt·JournalNature Structural & Molecular Biology·TypeExperimental study·DateJul 13, 2023

Engineered approach to remove protein aggregates from cells

A new study describes an engineered approach that makes protein aggregates amenable to spatial manipulations in both budding yeast and human cells. This system allows for the export of protein aggregates from cells, potentially protecting mother cells from toxicity and contributing to a better understanding of neurodegenerative diseases.

SourceUniversity of Gothenburg·JournalNature Communications·TypeExperimental study·DateJun 30, 2023

HKUST scientists achieve groundbreaking first by applying artificial intelligence for early risk forecasting of Alzheimer’s disease

Researchers at HKUST created an AI-based model that uses genetic data to forecast AD risk, outperforming existing models. The deep learning model accurately classifies patients and stratifies individuals into distinct risk groups, enabling early diagnosis and intervention.

SourceHong Kong University of Science and Technology·JournalCommunications Medicine·DateJun 7, 2023

A chance observation finds potential hearing biomarker for Alzheimer’s disease

Scientists at the University of Rochester Medical Center discovered a link between Alzheimer's disease and hearing loss in mice, finding that plaque location in the brain may contribute to hearing decline. The study suggests that tracking disease progression through amyloid PET imaging could be a potential biomarker for hearing loss.

SourceUniversity of Rochester Medical Center·JournalFrontiers in Neuroscience·DateJun 7, 2023

Insight into brain’s waste clearing system may shed light on brain diseases

Researchers at Washington University in St. Louis have found a way to enhance glymphatic transport using focused ultrasound with microbubbles, opening new opportunities for studying brain diseases and function. The non-invasive method shows promise for potentially mitigating neurodegenerative diseases like Alzheimer's and Parkinson's.

SourceWashington University in St. Louis·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMay 16, 2023

U of M researchers develop technique for rapid detection of neurodegenerative diseases like Parkinson’s and Chronic Wasting Disease

Researchers at the University of Minnesota have developed a new diagnostic technique called Nano-QuIC, which significantly improves protein-misfolding detection methods. The method reduces detection times from 14 hours to just four hours and increases sensitivity by a factor of ten.

SourceUniversity of Minnesota·JournalNano Letters·TypeExperimental study·DateMay 8, 2023

Dementia and self-harm: why it's crucial to support patients in first year after diagnosis

A large study found that people with dementia are at higher risk of self-harm within the first 12 months after diagnosis. The researchers emphasize the importance of providing psychosocial and mental health supports to patients upon diagnosis, particularly men, who are more likely to develop dementia after self-harm.

SourceUniversity of New South Wales·JournalAlzheimer s & Dementia·TypeSystematic review·DateMay 2, 2023

Study finds new pathway for clearing misfolded proteins

A new study at Stanford University found a previously unknown cellular pathway for clearing misfolded proteins from the nucleus. This pathway could be a target for therapies of age-related diseases like Alzheimer's, Parkinson's, and Huntington's. Cells use this pathway to manage misfolded proteins in both the cytoplasm and nucleus.

SourceStanford University·JournalNature Cell Biology·DateApr 20, 2023